Muse Treatment Alcohol & Drug Rehab Los Angeles has released a comprehensive new educational resource addressing withdrawal ...

University of Rhode Island Clinical Professor of Pharmacy Jeffrey Bratberg partnered with Brandeis University and Boston ...

Three new studies reveal surprising insights on GLP-1 weight loss drugs, opioid treatment in pregnancy, and the real science ...

Cannabinoids may reduce symptoms of some substance use and mental disorders, but the quality of evidence was mostly low in a systematic review and meta-analysis. The only finding of benefit with a ...

JailsoutpaceprisonsinofferingMOUD,butregionaldisparitiesandlimitedtreatmentaccess persist across the U.S. Qualitativefeedbackpointstoneedforgreaterreentrysupport,housing,carecoord ...

Researchers examined 54 clinical trials to see if cannabis helps treat mental health or addiction issues. They found minimal proof of benefit, alongside a higher risk of mild side effects like ...

This week's Trivia Tuesday question revisits a device designed to prevent opioid overdoses. Why did readers respond so ...

In the early 2000s, Michelle Warfield worked at a factory, hauling heavy seats for Ford trucks on and off an assembly line.

A large new study has revealed that cannabis doesn't help with anxiety, PTSD, or other mental health conditions ...

The national Six Remnant Defendants lawsuit was brought Feb. 23. The total compensation paid to participating governments would be nearly $98 million.

Extended-release buprenorphine was an effective treatment for pregnant women with opioid use disorder (OUD) and safe for their babies, according to an open-label randomized trial.

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.